Congressman Michael McCaul

Representing the 10th District of Texas

In the News

Oct 6, 2017 In the News

Congressman Michael McCaul huddled with Katy and local officials regarding a possible new reservoir to be built near Katy.

McCaul said early projects for the reservoir are projected in the $550-600 million range but added that is a project that was planned 1940 but was aborted due to money issues.

Sep 19, 2017 In the News

Families struggling with childhood cancer could soon have more options. That’s after President Trump signed the RACE for Children Act, a new law that allows drugs that fight cancer for adults to be tested and regulated to fight childhood cancer. The law was sponsored by Central Texas Republican Congressman Michael McCaul, R-Austin.

Sep 5, 2017 In the News

Congress so far this session has passed 55 bills that have been signed into law including dozens with bipartisan support, from sanctioning North Korea to reauthorizing the FDA, allowing the agency to continue to collect outside funding for medical research and offer more hope to children with cancer.

Aug 22, 2017 In the News

A new law, introduced by U.S. Rep. Michael McCaul, R-Austin, and a group of bipartisan lawmakers, could make it easier for children with cancer to battle the disease with the help of adult cancer drugs.

Jul 28, 2017 In the News

The top homeland security Republican in the House unveiled a border security bill Friday that would codify President Donald Trump's border wall, boost resources for Border Patrol and authorize the National Guard and Defense Departm

Dec 6, 2016 In the News

The Washington Times

By: Dave Boyer

December 6, 2016

Oct 14, 2016 In the News

Rep. Michael McCaul has submitted bipartisan legislation to provide border sheriffs and other local law enforcement agencies along the northern and southern borders $2.5 billion in federal assistance over five years.

Sep 19, 2014 In the News
Friends say Andrea Sloan would have loved to attend a summit this weekend in Washington, D.C., that will focus on research for childhood cancer and expanded access to experimental drugs for all cancer patients. Sloan, 45, passed away earlier this year after a fight to gain access to an experimental drug to treat her ovarian cancer through a process called compassionate use. She was eventually granted access to a different drug made by a different company, but by then, her cancer had progressed too far.
Jul 31, 2014 In the News
Regeneron Pharmaceuticals Inc. and Sanofi SA are spending $67.5 million on a novel bet they hope will help them outflank Amgen Inc. in the race to get a new class of cholesterol drugs to the market. The companies are paying the money to acquire a special voucher held by BioMarin Pharmaceuticals Inc. in a bid to hasten regulatory review of their drug alirocumab, one of an emerging group of medicines that lower cholesterol by targeting a gene known as PCSK9.